Outcomes for Medicare Asthma Patients Taking Fluticasone Propionate/Salmeterol Xinafoate Combination Versus Inhaled Corticosteroids or Other Combination Therapy

NCT01347060 · clinicaltrials.gov ↗

COMPLETED

Status

17448

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: fluticasone propionate/salmeterol xinafoate combination
DRUG: inhaled corticosteroids

Sponsor

GlaxoSmithKline